mosaec

Embattled Alzheimer’s Researcher Is Charged With Fraud

Alzheimer's Disease Cassava Sciences Inc City College of New York City University of New York Clinical Trials Drugs (Pharmaceuticals) Ethics and Official Misconduct Falsification of Data Frauds and Swindling National Institutes of Health Wang, Hoau-Yan your-feed-science

Embattled Alzheimer’s Researcher Is Charged With Fraud

Hoau-Yan Wang, a professor at City College, published studies supporting simufilam, now in advanced clinical trials.

By Apoorva Mandavilli

Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug

Alzheimer's Disease Biogen Inc Brain Clinical Trials donanemab Drugs (Pharmaceuticals) Eisai Co Ltd Eli Lilly and Company Food and Drug Administration Leqembi (Drug) Memory United States your-feed-healthcare your-feed-science

Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug

The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.

By Gina Kolata and Pam Belluck

Alzheimer’s Takes a Financial Toll Long Before Diagnosis, Study Finds

Alzheimer's Disease Credit and Debt Dementia Elderly Federal Reserve Bank of New York Georgetown University Personal Finances Research

Alzheimer’s Takes a Financial Toll Long Before Diagnosis, Study Finds

New research shows that people who develop dementia often begin falling behind on bills years earlier.

By Ben Casselman